Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [5258]

Clinically distinct subgroups identified in paediatric medulloblastoma

Clinically distinct subgroups identified in paediatric medulloblastoma

Direct injection of p53 activator to lesion increases tumor destruction, decreases toxicity

Direct injection of p53 activator to lesion increases tumor destruction, decreases toxicity

One in 5 cancers diagnosed in the United States is a rare cancer

One in 5 cancers diagnosed in the United States is a rare cancer

Assessing personalised therapy targets leads to discovery of new options

Assessing personalised therapy targets leads to discovery of new options

FDA approves pembrolizumab for relapsed/cisplatin ineligible metastatic urothelial carcinoma

FDA approves pembrolizumab for relapsed/cisplatin ineligible metastatic urothelial carcinoma

Scientists to test Zika virus on brain tumours

Scientists to test Zika virus on brain tumours

Comprehensive cancer study assesses potential targets for personalized medicine and finds new ones

Comprehensive cancer study assesses potential targets for personalized medicine and finds new ones

Brigatinib offers over 1-year control of ALK-positive lung cancer post-crizotinib

Brigatinib offers over 1-year control of ALK-positive lung cancer post-crizotinib

New antibody drug could be used to target treatment-resistant childhood leukaemia

New antibody drug could be used to target treatment-resistant childhood leukaemia

ASCO 2017: Deficiencies in repair of DNA identified in many types of solid tumours

ASCO 2017: Deficiencies in repair of DNA identified in many types of solid tumours

More from ecancer